Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5650168
SERIAL NO

08537853

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention concerns tablets with improved bioavailability of the active substance dichloromethylenediphosphonic acid or of a physiologically tolerated salt thereof and with a content of microcrystalline cellulose as a pharmaceutical auxiliary substance, pharmaceutical packs containing these tablets, the use of the active substance dichloromethylenediphosphonic acid together with microcrystalline cellulose for the production of a tablet with improved bioavailability and the process for producing the tablet.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RIEMSER ARZNEIMITTEL AGGERMAN RIMES RIETHEIM-WEILHEIM BADEN-WURTTEMBERG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gabel, Rolf-Dieter Schwetzingen, DE 23 467
Musel, Bernd Worms, DE 1 5
Neugebauer, Gunther Mannheim, DE 1 5
Preis, Walter Neustadt, DE 15 119

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation